These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 11392449

  • 1. Oral delivery of taxanes.
    Malingré MM, Beijnen JH, Schellens JH.
    Invest New Drugs; 2001 May; 19(2):155-62. PubMed ID: 11392449
    [Abstract] [Full Text] [Related]

  • 2. Co-administration of cyclosporin enables oral therapy with paclitaxel.
    Meerum Terwogt JM, Beijnen JH, ten Bokkel Huinink WW, Rosing H, Schellens JH.
    Lancet; 1998 Jul 25; 352(9124):285. PubMed ID: 9690410
    [No Abstract] [Full Text] [Related]

  • 3. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ, Lagas JS, Rosing H, Schellens JH, Beijnen JH, Schinkel AH.
    Int J Cancer; 2013 May 15; 132(10):2439-47. PubMed ID: 23090875
    [Abstract] [Full Text] [Related]

  • 4. Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.
    Bardelmeijer HA, Ouwehand M, Buckle T, Huisman MT, Schellens JH, Beijnen JH, van Tellingen O.
    Cancer Res; 2002 Nov 01; 62(21):6158-64. PubMed ID: 12414642
    [Abstract] [Full Text] [Related]

  • 5. Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.
    van Asperen J, van Tellingen O, Sparreboom A, Schinkel AH, Borst P, Nooijen WJ, Beijnen JH.
    Br J Cancer; 1997 Nov 01; 76(9):1181-3. PubMed ID: 9365166
    [Abstract] [Full Text] [Related]

  • 6. Enhanced oral bioavailability of docetaxel by coadministration of cyclosporine: quantitation and role of P-glycoprotein.
    Chiou WL, Wu TC, Ma C, Jeong HY.
    J Clin Oncol; 2002 Apr 01; 20(7):1951-2; author reply 1952. PubMed ID: 11919259
    [No Abstract] [Full Text] [Related]

  • 7. Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel.
    Malingré MM, Richel DJ, Beijnen JH, Rosing H, Koopman FJ, Ten Bokkel Huinink WW, Schot ME, Schellens JH.
    J Clin Oncol; 2001 Feb 15; 19(4):1160-6. PubMed ID: 11181682
    [Abstract] [Full Text] [Related]

  • 8. Taxanes: old drugs, new oral formulations.
    Jibodh RA, Lagas JS, Nuijen B, Beijnen JH, Schellens JH.
    Eur J Pharmacol; 2013 Oct 05; 717(1-3):40-6. PubMed ID: 23660368
    [Abstract] [Full Text] [Related]

  • 9. Initial pharmacokinetics and bioavailability of PSC 833, a P-glycoprotein antagonist.
    Lush RM, Meadows B, Fojo AT, Kalafsky G, Smith HT, Bates S, Figg WD.
    J Clin Pharmacol; 1997 Feb 05; 37(2):123-8. PubMed ID: 9055138
    [Abstract] [Full Text] [Related]

  • 10. Individual and combined roles of CYP3A, P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) in the pharmacokinetics of docetaxel.
    van Waterschoot RA, Lagas JS, Wagenaar E, Rosing H, Beijnen JH, Schinkel AH.
    Int J Cancer; 2010 Dec 15; 127(12):2959-64. PubMed ID: 21351274
    [Abstract] [Full Text] [Related]

  • 11. P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel.
    Kimura Y, Aoki J, Kohno M, Ooka H, Tsuruo T, Nakanishi O.
    Cancer Chemother Pharmacol; 2002 Apr 15; 49(4):322-8. PubMed ID: 11914912
    [Abstract] [Full Text] [Related]

  • 12. Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation.
    Hendrikx JJ, Lagas JS, Wagenaar E, Rosing H, Schellens JH, Beijnen JH, Schinkel AH.
    Br J Cancer; 2014 May 27; 110(11):2669-76. PubMed ID: 24781280
    [Abstract] [Full Text] [Related]

  • 13. Enhanced oral absorption and decreased elimination of paclitaxel in mice cotreated with cyclosporin A.
    van Asperen J, van Tellingen O, van der Valk MA, Rozenhart M, Beijnen JH.
    Clin Cancer Res; 1998 Oct 27; 4(10):2293-7. PubMed ID: 9796957
    [Abstract] [Full Text] [Related]

  • 14. Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093).
    Kuppens IE, Bosch TM, van Maanen MJ, Rosing H, Fitzpatrick A, Beijnen JH, Schellens JH.
    Cancer Chemother Pharmacol; 2005 Jan 27; 55(1):72-8. PubMed ID: 15316750
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice.
    Bardelmeijer HA, Ouwehand M, Beijnen JH, Schellens JH, van Tellingen O.
    Invest New Drugs; 2004 Aug 27; 22(3):219-29. PubMed ID: 15122069
    [Abstract] [Full Text] [Related]

  • 16. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB, Valero V, Hortobagyi G.
    Drug Saf; 2000 Nov 27; 23(5):401-28. PubMed ID: 11085347
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of oral cyclosporin A when co-administered to enhance the absorption of orally administered docetaxel.
    Malingré MM, Ten Bokkel Huinink WW, Mackay M, Schellens JH, Beijnen JH.
    Eur J Clin Pharmacol; 2001 Jul 27; 57(4):305-7. PubMed ID: 11549208
    [Abstract] [Full Text] [Related]

  • 18. Metabolism and excretion of paclitaxel after oral administration in combination with cyclosporin A and after i.v. administration.
    Malingré MM, Schellens JH, van Tellingen O, Rosing H, Koopman FJ, Duchin K, Huinink WW, Swart M, Beijnen JH.
    Anticancer Drugs; 2000 Nov 27; 11(10):813-20. PubMed ID: 11142688
    [Abstract] [Full Text] [Related]

  • 19. A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A.
    Malingré MM, Beijnen JH, Rosing H, Koopman FJ, van Tellingen O, Duchin K, Ten Bokkel Huinink WW, Swart M, Lieverst J, Schellens JH.
    Cancer Chemother Pharmacol; 2001 Apr 27; 47(4):347-54. PubMed ID: 11345652
    [Abstract] [Full Text] [Related]

  • 20. Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.
    Bardelmeijer HA, Beijnen JH, Brouwer KR, Rosing H, Nooijen WJ, Schellens JH, van Tellingen O.
    Clin Cancer Res; 2000 Nov 27; 6(11):4416-21. PubMed ID: 11106262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.